Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia

Section of Cardiology, Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA. johnj@bcm.tmc.edu

OBJECTIVES: We sought to determine the effects of nicotine patch therapy, when used to promote smoking cessation, on myocardial ischemia in patients with coronary artery disease. BACKGROUND: Nicotine patches substantially increase quit rates among cigarette smokers, but their safety in patients with myocardial ischemia who are attempting to quit smoking is unknown. METHODS: This is a prospective study using exercise thallium-201 single-photon emission computed tomography (SPECT) to assess serial changes in the total and ischemic myocardial perfusion defect size at baseline while patients were smoking and during treatment with 14- and 21-mg nicotine patches. Entry criteria required that patients 1) smoked > or = 1 pack of cigarettes per day; 2) had known coronary artery disease; and 3) had myocardial ischemia (i.e., > or = 5% reversible perfusion defect) on SPECT. All patients performed symptom-limited treadmill exercise, and the baseline SPECT study served as its own control. We interpreted and computer quantified the SPECT images with no knowledge of the testing sequence. RESULTS: Thirty-six of the 40 enrolled patients had exercise SPECT at baseline and during treatment with at least 14-mg nicotine patches. These patients had an initial perfusion defect size of 17.5 +/- 10.6% while smoking an average of 31 +/- 11 cigarettes per day for 40 +/- 12 years. A significant reduction in the total perfusion defect size (p < 0.001) was observed from baseline (17.5 +/- 10.6%) to treatment with 14-mg (12.6 +/- 10.1%) and 21-mg (11.8 +/- 9.9%) nicotine patches. This reduction occurred despite an increase in treadmill exercise duration (p < 0.05) and higher serum nicotine levels (p < 0.001). There was a significant correlation between the reduction in defect size and exhaled carbon monoxide levels (p < 0.001) because patients reduced their smoking by approximately 74% during the trial. CONCLUSIONS: Nicotine patches, when used to promote smoking cessation, significantly reduce the extent of exercise-induced myocardial ischemia as assessed by exercise thallium-201 SPECT.

This article has been cited by other articles:

				R Hubbard, S Lewis, C Smith, C Godfrey, L Smeeth, P Farrington, and J Britton Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death Tob. Control, December 1, 2005; 14(6): 416 - 421. [Abstract] [Full Text] [PDF]

				D. O. Warner Helping Surgical Patients Quit Smoking: Why, When, and How Anesth. Analg., August 1, 2005; 101(2): 481 - 487. [Abstract] [Full Text] [PDF]

				C. L. Ford and J. A. Zlabek Nicotine Replacement Therapy and Cardiovascular Disease Mayo Clin. Proc., May 1, 2005; 80(5): 652 - 656. [Abstract] [PDF]

				R. Gupta, H. Gurm, and J. R. Bartholomew Smokeless Tobacco and Cardiovascular Risk Arch Intern Med, September 27, 2004; 164(17): 1845 - 1849. [Abstract] [Full Text] [PDF]

				X. Wang, J. Zhu, J. Chen, and Y. Shang Effects of Nicotine on the Number and Activity of Circulating Endothelial Progenitor Cells J. Clin. Pharmacol., August 1, 2004; 44(8): 881 - 889. [Abstract] [Full Text] [PDF]

				C. L. Grines, M. W. Watkins, J. J. Mahmarian, A. E. Iskandrian, J. J. Rade, P. Marrott, C. Pratt, N. Kleiman, and for the Angiogenic GENe Therapy (AGENT-2) Study Gr A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1339 - 1347. [Abstract] [Full Text] [PDF]

				N. L. Benowitz Basic cardiovascular research and its implications for the medicinal use of nicotine J. Am. Coll. Cardiol., February 5, 2003; 41(3): 497 - 498. [Full Text] [PDF]

				T. D. Rea, S. R. Heckbert, R. C. Kaplan, N. L. Smith, R. N. Lemaitre, and B. M. Psaty Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction Ann Intern Med, September 17, 2002; 137(6): 494 - 500. [Abstract] [Full Text] [PDF]

				J. E. Anderson, D. E. Jorenby, W. J. Scott, and M. C. Fiore Treating Tobacco Use and Dependence : An Evidence-Based Clinical Practice Guideline for Tobacco Cessation Chest, March 1, 2002; 121(3): 932 - 941. [Abstract] [Full Text] [PDF]

				M.P. Pellegrini, D. E Newby, S. Maxwell, and D. J Webb Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man Cardiovasc Res, November 1, 2001; 52(2): 321 - 327. [Abstract] [Full Text] [PDF]

				T.P. Mathew and N.A. Herity Acute myocardial infarction soon after nicotine replacement therapy QJM, September 1, 2001; 94(9): 503 - 504. [Full Text] [PDF]

				S. E. Kimmel, J. A. Berlin, C. Miles, J. Jaskowiak, J. L. Carson, and B. L. Strom Risk of acute first myocardial infarction and use of nicotine patches in a general population J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1297 - 1302. [Abstract] [Full Text] [PDF]

				D Balfour, N Benowitz, K Fagerstrom, M Kunze, and U Keil Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report Eur. Heart J., March 2, 2000; 21(6): 438 - 445. [Abstract] [PDF]

				H. A. Dakik, N. S. Kleiman, J. A. Farmer, Z.-X. He, J. A. Wendt, C. M. Pratt, M. S. Verani, and J. J. Mahmarian Intensive Medical Therapy Versus Coronary Angioplasty for Suppression of Myocardial Ischemia in Survivors of Acute Myocardial Infarction : A Prospective, Randomized Pilot Study Circulation, November 10, 1998; 98(19): 2017 - 2023. [Abstract] [Full Text] [PDF]

				Nicotine Patch Safe in Stable CAD Journal Watch Cardiology, August 18, 1997; 1997(818): 10 - 10. [Full Text]